Vascular Complications in Children With Type 1 Diabetes

Vascular Complications in Children From T1D Diagnosis

Recruiting Observational Study
Type 1 Diabetes Cardiovascular Complications Child Adolescent
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
8 – 18
Sex
Any
Study type
Observational
Participants needed
150 (estimated)
Sponsor
University of British Columbia · Other
Who this trial is looking for

This trial is looking for children and teens aged 8 to 18 who have been diagnosed with type 1 diabetes within the last 14 weeks. Participants will need to undergo non-invasive testing related to their blood vessels and wear a device that monitors blood pressure for 24 hours.

Are You a Good Fit for This Trial?
Rules you out Type 2 diabetesLupus

You may be able to join if

  • I am between 8 and 18 years old.
  • I was diagnosed with type 1 diabetes within the last 14 weeks.
  • I am willing to undergo a non-invasive arterial stiffness assessment for 1 hour.
  • I am willing to wear a 24-hour automated blood pressure monitoring device.

You may not be able to join if

  • I have another cardiometabolic or endocrine disease.
  • I have a genetic syndrome like Down Syndrome or Prader-Willi.
  • I have an eating disorder.
  • I am a transgender child taking hormone blockers or exogenous sex steroids.
  • I am currently taking medications that affect metabolism.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

Cardiovascular disease is a complication of type 1 diabetes (T1D), a life-long disease, usually diagnosed in childhood. The goal of this project is to determine the timing and factors leading to vascular damage in children from T1D diagnosis.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria 1. Between the ages of 8-18 years 2. Within 14 weeks of type 1 diabetes diagnosis 3. Ability and willingness to undergo non-invasive arterial stiffness assessment for 1hr and willingness to wear the 24-h automated blood pressure monitoring (ABPM) device. Exclusion Criteria Chil…
Contacts

Angela Devlin, PhD

6048752000

adevlin@bcchr.ubc.ca

CONTACT

Constadina Panagiotopoulos, MD

dpanagiotopoulos@cw.bc.ca

CONTACT